Reliability and validity of the European Portuguese version of the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
ARP Rheumatology · 2025
DOI: 10.63032/dboo2665 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift ARP Rheumatology, 2025. Verfasst von Marcelo Neto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unidade Local de Saúde de Coimbra. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Quality of Life. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Unidade Local de Saúde de Coimbra.
- Centro de Medicina de Reabilitação da Região Centro-Rovisco Pais.
- Instituto Português de Oncologia do Porto.
- University of Leeds.
Zitieren
APA
Neto, M., Albuquerque, F., Patrício, R., Vieira, M., Fernandes, R., Silva, A., Salvador, M. J., & Santiago, T. (2025). Reliability and validity of the European Portuguese version of the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire. ARP Rheumatology. https://doi.org/10.63032/dboo2665
Vancouver
Neto M, Albuquerque F, Patrício R, Vieira M, Fernandes R, Silva A, et al. Reliability and validity of the European Portuguese version of the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire. ARP Rheumatology. 2025. doi:10.63032/dboo2665
BibTeX
@article{Neto2025,
author = {Neto, Marcelo and Albuquerque, Fernando and Patrício, Rodrigo and Vieira, Margarida and Fernandes, Ruben and Silva, Anabela and Salvador, Maria João and Santiago, Tânia},
title = {Reliability and validity of the European Portuguese version of the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire},
journal = {ARP Rheumatology},
year = {2025},
doi = {10.63032/dboo2665}
}
EUVIMED